Earlier brain imaging studies have shown how the focusing process works in healthy people. When they undergo tasks that depend exclusively on visual clues, they not only activate the areas of the brain involved in visual processing but also de-activate those areas that have to do with auditory processing. The reverse activation/de-activation pattern is seen when the clues are exclusively auditory. The phenomenon, called "cross-modal auditory/visual de-activation", is thought to help with focusing the information processing capacities of the brain on the relevant areas.
To test whether cross-modal inhibition is affected in AD, Alexander Drzezga and colleagues examined the activation and de-activation patterns in the brains of patients with AD and individuals with mild cognitive impairment (MCI). The researchers tested 32 participants: 11 healthy individuals, 11 individuals with mild cognitive impairment, and 10 individuals with moderate AD.
The participants were trained to perform a navigation task, based exclusively on visual clues, in a virtual reality environment. All participants understood the task and the clues. They then each completed 12 separate PET scans, 8 during active navigation, finding their way from a start point to a specific destination, and 4 under control conditions, traveling along a never-ending pathway. The tasks were performed in complete silence.
The three groups differed in their performance, measured by the time needed to reach the destination, as would be expected. In the scans, the researchers saw significant differences in brain activation patterns, but most striking were differences in the ability to inhibit irrelevant activity. Healthy individuals showed strong bilateral de-activation in the auditory cortex. Auditory de-activation was much less prominent in individuals with MCI, and totally absent in individuals with AD.
Alexander Drzezga and colleagues propose that the patients' orientation disability in the outside world may be partially caused by their inability to selectively focus brain activity in task-relevant areas. They are now in the middle of a follow-up study that concentrates on individuals with MCI, some of whom remain stable for years whereas others progress to AD, to see whether the extent of cross-modal inhibition correlates with progression to disease. Preliminary results suggest that it does.